ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
US clears Pfizer, Myovant's Myfembree for fibroid-associated menstrual bleeding
May 27, 2021Pfizer and Myovant Sciences announced Wednesday that the FDA has approved Myfembree,which combines the GnRH antagonist relugolix with hormones estradiol and norethindrone, to manage heavy menstrual bleeding in premenopausal women who have uterine fibroids
Pharma Sources Insight January 2025
